Trial Profile
Does the DPP4 Inhibitor (Sitagliptin) Increase Endometrial Mesenchymal Stem Cells in Women with Recurrent Miscarriage?
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Mar 2019
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Spontaneous abortion
- Focus Therapeutic Use
- Acronyms SIMPLANT
- 02 Jun 2017 Status changed from recruiting to active, no longer recruiting.
- 06 Feb 2017 New trial record
- 19 Dec 2016 Status changed from active, no longer recruiting to completed.